Press releases

September, 2022

FRISQ extends the exclusive period for Cambio to make a final offer regarding FRISQ Holding’s operative business

As previously announced, the Board of FRISQ Holding AB ("FRISQ") has decided to initiate a formal, exclusive process with the objective to divest its operative business to Cambio Healthcare Systems AB ("Cambio"). The discussions held between the parties have been positive and both parties intend to complete the transaction as soon as possible. Certain technical details are currently being investigated and Cambio has therefore asked FRISQ to extend the exclusive period by up to...
August, 2022

Capio Elderly and Mobile Care signs new commercial agreements with FRISQ

After a broad introduction of FRISQ Care in 31 units within Capio Elderly and Mobile Care, they now sign new agreements with FRISQ. The agreements concern an introduction of FRISQ Care in new units as well as an expanded implementation and support assignment. The agreements run for 4 years, and the order value is approximately SEK 1.6 million with possible additions for development and implementation.

FRISQ’s Interim Report Q2, 2022

CEO Statement During the quarter, Sweden approached the healthcare crisis we’re now in, and the summer months have been extremely challenging in many parts of the country. The health care situation means that the need for solutions that can help relieve the system without lowering the quality of care is both great and clear. We know that FRISQ can contribute to this and that became clear to many who listened to Capio's seminar at Vitalis where they highlighted some of the benefits of FRISQ, including i...
July, 2022

FRISQ enters into a formal exclusive process to divest the business to Cambio with a target transaction date in September 2022. CEO George Thaw steps down.

The Board of Directors of FRISQ Holding AB (FRISQ”) has decided to enter into a formal exclusive process with the objective to divest its operative business to Cambio Health Care System AB (“Cambio”). After several months of exploring the best options to secure the continued development of FRISQ, the Board has decided to accept a proposal from Cambio. Both parties see large synergies in a potential deal and are optimistic about achieving a successful transaction. The proposal is to enter into an exc...
May, 2022

Correction: Interim Report Q1, 2022

The correction refers to the EU Market Abuse Regulation.

Interim Report Q1, 2022

CEO Statement During the quarter, we have expanded our cooperation with the private healthcare provider, Capio. In addition to the multi-year agreement with Capio Elderly and Mobile Care, Capio Orthopedics signed a 3-year agreement with us. The new agreement was signed after a successful pilot project, which really proves that FRISQ Care brings value that our customers are willing to pay for. I’m very proud of the results highlighted by Capio Orthopedics that shows that the use of FRISQ Care helps C...

Announcement from FRISQ’s annual general meeting

The annual general meeting ("AGM") of Frisq Holding AB (publ) ("FRISQ" or the "Company") was held today on 5 May 2022 in Stockholm and the following resolutions were passed by the meeting. Adoption of the income statement and the balance sheetThe AGM resolved to adopt the income statement and the balance sheet in FRISQ and the consolidated income statement and the consolidated balance sheet. Allocation of profitThe AGM resolved that no dividend would be paid to the s...
April, 2022

FRISQ announces the outcome of the rights issue

FRISQ Holding AB (publ) (“FRISQ” or the “Company”) hereby announces the outcome of the rights issue as resolved by the board of directors on 17 March 2022 (the “Rights Issue”). In total 2,236,015 shares were subscribed, corresponding to approximately 18.65 percent of the Rights Issue. The Rights Issue thus provides the Company with approximately SEK 2.2 million before deductions of costs related to the Rights Issue.

FRISQ’s Annual Report for 2021 is published

The FRISQ Annual Report for 2021 is now available in Swedish on the www.frisqholding.se website. The annual report partly deviates regarding the parent company's accounts compared with what was previously published in the year-end report.

Notice of annual general meeting in Frisq Holding AB (publ)

The shareholders of Frisq Holding AB (publ), reg. no. 556959-2867, (the "Company"), are hereby convened to the annual general meeting to be held on Thursday 5 May 2022, at 14.00 at Baker & McKenzie's premises at Vasagatan 7 in Stockholm. Right to attend the annual general meeting and notice   Shareholders wishing to attend the annual general meeting must: i.         on the record date, which is Wednesday 27 April 2022, be registered in the share register maintained by Euroclear Sweden AB; and ...
March, 2022

FRISQ to conduct a rights issue of SEK 12 million

As previously communicated, The Board of Directors of FRISQ Holding AB (“FRISQ” or the “Company”) has decided, based on authorization by a shareholders’ meeting, to conduct a new share issue of a maximum 11,988,693 shares at a subscription price of one (1) SEK per share, with preferential rights for the Company’s existing shareholders (the “Rights Issue”). The proceeds from the Rights Issue may bring proceeds to the Company at a maximum of approximately SEK 12 million, before deduction of costs. In ad...

Additional information regarding FRISQ Holding’s directed new issue of shares

FRISQ Holding AB has, as previously been communicated, carried out a directed new issue of 18,150,000 shares at the price of one (1) SEK per share.The share issue was to 80% subscribed by existing shareholders with Nordica Life Insurance for its customers (8 MSEK) and Nordic Cross Asset Management AB (1.5 MSEK) as largest subscribers. New investors with no previously ownership in the company subscribed to 20% of the new issue. The largest subscribers were Gryningskust Holding AB (2 MSEK) and City...

Business update from FRISQ

FRISQ Holding AB has, as previously communicated, carried out a directed share issue of 18,150,000 shares at the issue price of one (1) SEK per share. This new share issue will be followed up by a rights issue to all shareholders of a maximum of 13.8 million shares at the same issue price. The details of this rights issue will be published next week. With the added capital, FRISQ intends to accelerate the company's positive commercial development with focus on the Swedish market. After almost ...

FRISQ Holding AB decides on a new share issue to secure the company’s financial position

FRISQ Holding AB (“FRISQ” or “the Company”) has in a previous press release announced its intention to decide on a new share issue. FRISQ has now secured a new share issue. As the board of FRISQ didn’t receive a signed and binding share transfer agreement from Tempest SPV Ltd on Monday, the Board has, with the mandate of the Extraordinary General Meeting, decided on a new share issue which may provide FRISQ up to 32 million SEK. The new issue is divided into a directed issue and then a rights iss...

FRISQ Holding AB intends to decide on a new share issue to secure the company’s financial position

As the board of FRISQ Holding AB (hereinafter "Frisq" or "the Company") did not receive a signed and binding share purchase agreement from Tempest SPV Ltd on Monday, the board intends to decide on a new share issue with the authorization given at the Extraordinary General Meeting. The purpose of the new share issue is to secure the Company's financial position. The authorization enables the issue of up to approximately 31.9 million shares. The Board intends to carry out ...

Report Q4 and Full Year 2021

January-December 2021 CEO Statement The hope that healthcare could look to the time after the pandemic, including the necessary innovation work needed, were once again sharply shaken when the Omicron variant created a new wave in the last quarter of 2021 . We are therefore extra proud of what we have managed to achieve despite these external challenges. The collaboration with pharmaceutical companies USB and Amgen breaks new grounds for us as a business and shows that FRISQ Care can add value in...
February, 2022

Update regarding the divestment of FRISQ Holding AB’s subsidiaries

At the Extraordinary General Meeting on February 22nd 2022, the shareholders present voted in favor of a sale of FRISQ Holding's subsidiaries to Tempest SPV Ltd, subject to the conditions that the purchase price was not changed (SEK 106.4 million), the share purchase agreement took place on market terms and that signing would take place no later than February 28th 2022, 23.59 CET. Due to a serious illness, the buyer has requested a deferral of submitting a signed and binding share purchase agreement....

FRISQ Holding is pushing forward the year-end report

In view of the decision taken at the Extraordinary General Meeting on 22 February 2022, the Board of Directors of FRISQ Holding AB has decided to postpone the year-end report for 2021 to be able to complete a possible sale of the subsidiaries. New date for the report is Wednesday, March 2 at 08.00 CET, 2022. For further information:George Thaw, CEO, FRISQinvestor@frisq.se About FRISQ:FRISQ is a healthtech company built on the conviction that the quality of the care you get should not be dependent ...

Announcement from FRISQ’s continued extra general meeting

The extra general meeting ("EGM") of Frisq Holding AB (publ) ("FRISQ" or the "Company") was held today on 22 February 2022 and the following resolutions were passed by the meeting. Resolution on approval of the sale of all shares in the subsidiariesThe extra general meeting has today resolved to approve the sale of all shares in the company's operating subsidiaries Frisq AB, Frisq UK LTD and Frisq USA Holding Inc, conditional on the purchase price for the shares ...

Improving maternity care with digitalised care plans

FRISQ and Aleris have together with Aleris-owned BB Stockholm and Ultragyn entered into a collaboration to implement a digital, interactive care plan in order to strengthen the collaboration between the prospective parent couple, the midwife clinic and the delivery unit. The ambition of the project is to streamline resource utilization through modernized working methods and to simplify and improve the care journey for both the pregnant woman and the care staff.

Information on resolution on continued extra general meeting in FRISQ

The extra general meeting ("EGM") of Frisq Holding AB (publ) ("FRISQ" or the "Company") was held on 8 February 2022 at 15:00 CET and the following resolutions were passed by the meeting. Adjournment of the issue of sale of all shares in the subsidiaries until 22 February 2022The EGM has decided to be adjourned and that a decision on the sale of all shares in the company's operating subsidiaries Frisq AB, Frisq UK LTD and Frisq USA Holding Inc shall be postponed ...

Announcement from FRISQ Holding AB’s extra general meeting held on February 8 at 14:00 CET

The extra general meeting ("EGM") of Frisq Holding AB (publ) ("FRISQ" or the "Company") was held today on 8 February 2022 at 14:00 CET and the following resolutions were passed by the meeting. Amendments of the Company's Articles of AssociationThe EGM resolved, in accordance with the board of directors' proposal, to amend the articles of association's object of the Company to include own and manage moveable property, in addition to, or instead of, the ...

Update regarding offer on FRISQ’s operating subsidiaries

As previously announced, The Board of Directors (“Board”) of FRISQ Holding AB (publ) ("FRISQ" or "the Company") has received a non-binding offer for the Company's operating subsidiaries FRISQ AB, FRISQ UK LTD and FRISQ USA Holding Inc (together the "Subsidiaries") for a total purchase price of approximately SEK 106 million. The offer has been submitted by Kerdos Capital Ventures Ltd ("Kerdos"). As a result hereof, the Board has convened an Extraordinary Gen...
January, 2022

CORRECTION REGARDING NOTICE OF EXTRA GENERAL MEETINGS IN FRISQ

The correction refers to the date of registration for the two extra general meetings on 8 February 2022. The last date for registration and submission of documentation for proxies, proxy forms, etc.to the extra general meetings is 2 February 2022. In previously published notices, it is stated that the last date for registration and submission of documentation for proxies, proxy forms etc. to the extra general meetings was 1 February 2022. Frisq Holding AB (publ) have today updated the notices and...

Notice of extra general meeting in Frisq Holding AB (publ)

The shareholders of Frisq Holding AB (publ), reg. no. 556959-2867, (the "Company"), are hereby convened to the extra general meeting to be held on Tuesday 8 February 2022, at 15.00 CET at Baker & McKenzie's premises at Vasagatan 7 in Stockholm. The general meeting is scheduled to take place immediately after a first extra general meeting to which a separate notice has been sent out previously. Right to attend the extra general meeting and notice   Shareholders wishing to attend the extra general ...

FRISQ expands its collaboration with Capio through a new agreement with Capio Orthopedics

After a 12-month pilot project, Capio Orthopedics now signs a three-year agreement with FRISQ. The purpose of the agreement is to introduce the digital process support FRISQ Care in all Capio Orthopedics units in accordance with the offered licensing and implementation costs.

FRISQ has received an offer regarding a divestment of its operating subsidiaries

Insider information: The Board of Directors (“Board”) of FRISQ Holding AB (publ) ("FRISQ" or "the Company") has received an offer for the Company's operating subsidiaries FRISQ AB, FRISQ UK LTD and FRISQ USA Holding Inc (together the "Subsidiaries") for a total purchase price of approximately SEK 106 million. The non-binding offer has been submitted by Kerdos Capital Ventures Ltd ("Kerdos").

Notice of extra general meeting in Frisq Holding AB (publ)

The shareholders of Frisq Holding AB (publ), reg. no. 556959-2867, (the "Company"), are hereby convened to the extra general meeting to be held on Tuesday 8 February 2022, at 14.00 at Baker & McKenzie's premises at Vasagatan 7 in Stockholm. Right to attend the extra general meeting and notice   Shareholders wishing to attend the extra general meeting must: i.         on the record date, which is Monday 31 January 2022, be registered in the share register maintained by Euroclear Sweden AB; and ...